NASDAQ:VTGN

Vistagen Stock at 63 Cents: The June Trial Readout Traders Are Watching
····

Vistagen Stock at 63 Cents: The June Trial Readout Traders Are Watching

Vistagen Therapeutics shares traded near $0.63 ahead of Monday’s Nasdaq open as investors awaited Phase 3 trial data for its lead anxiety drug, fasedienol. The company, valued at $26.6 million, expects topline results from the PALISADE-4 study this quarter. Vistagen will present at the Jefferies Healthcare Conference in New York June 2–4. The stock closed Friday at $0.630 on 654,000 shares traded.
June 1, 2026

Stock Market Today

  • Wise Shares Fall Amid Belgian Money Laundering Probe
    June 1, 2026, 11:29 AM EDT. Wise, the UK-based international money transfer firm valued at over £8bn, is under investigation by Belgian prosecutors over money laundering concerns. The probe centers on alleged use of Wise accounts for laundering proceeds from fraud, corruption, and drug trafficking, involving around €500m in transactions. Wise is cooperating with authorities and emphasizes ongoing efforts to prevent financial crime through customer verification and transaction monitoring. Following confirmation of the investigation, Wise shares dropped more than 10%. The company, which shifted its primary listing to the US in 2024, had its co-founder fined £350,000 earlier this year for regulatory violations. This investigation highlights regulatory scrutiny on fintechs amid rising concerns over financial crime compliance.